Physician profile
Atiq Budhani
NPI 1336560101
$1,319.61
in general payments reported to CMS, 2019-2025
19 companies · $26.93 in 2025
The $26.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2021: $129 · 2022: $105 · 2023: $631 · 2024: $125 · 2025: $26.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.07 | 2019-2023 | Ubrelvy |
| Novo Nordisk INC | $218.29 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Gilead Sciences, INC. | $125.00 | 2024 | Veklury |
| Astellas Pharma US INC | $107.82 | 2019-2023 | Myrbetriq |
| Lilly USA, LLC | $105.32 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.82 | 2019 | |
| Glaxosmithkline, LLC. | $89.60 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $47.71 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $40.36 | 2022-2023 | Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.62 | 2022-2023 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $29.85 | 2023 | |
| Merck Sharp & Dohme LLC | $29.08 | 2019-2022 | |
| Exact Sciences Corporation | $26.93 | 2025 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $23.19 | 2023 | Horizant |
| Supernus Pharmaceuticals, INC. | $21.19 | 2023 | Qelbree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.98 | 2023 | |
| Si-Bone, INC. | $19.69 | 2023 | |
| Upsher-Smith Laboratories LLC | $16.52 | 2023 | |
| Amgen INC. | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atiq Budhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.